Deborah A Tweddle

14PUBLICATIONS
175CO-AUTHORS
Predictive and prognostic markersCentral nervous systemHaematological tumoursCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 01, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

|Feb 13, 2026
Detection and Characterisation of Circulating Tumour Cell Clusters in Neuroblastoma.

Zoe Bell, Swathi Merugu, David Jamieson

|Dec 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Juliet C Gray, Rebekah Weston, Cormac Owens

|Oct 16, 2025
Detection of Targetable Genetic Abnormalities in Neuroblastoma Circulating Tumour DNA.

Marina Danilenko, Sharanya Nath, Jack Baines

|Dec 18, 2024
Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States.

Sally L George, Claire Lynn, Reda Stankunaite

|Oct 16, 2024
Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16, 998.

Julia Chisholm, Henry Mandeville, Madeleine Adams

Pageof 3

Frequent Collaborators

5 joint publications

Pascal Chastagner

5 joint publications

Pamela Kearns

5 joint publications

Sally L George

4 joint publications

Louis Chesler